Annual Accounts Receivable
$16.62 M
+$16.62 M+100.00%
December 31, 2023
Summary
- As of February 12, 2025, TARS annual accounts receivable is $16.62 million, with the most recent change of +$16.62 million (+100.00%) on December 31, 2023.
- TARS annual accounts receivable is now at all-time high.
Performance
TARS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$29.16 M
-$370.00 K-1.25%
September 30, 2024
Summary
- As of February 12, 2025, TARS quarterly accounts receivable is $29.16 million, with the most recent change of -$370.00 thousand (-1.25%) on September 30, 2024.
- Over the past year, TARS quarterly accounts receivable has increased by +$12.54 million (+75.43%).
- TARS quarterly accounts receivable is now -2.43% below its all-time high of $29.89 million, reached on March 31, 2024.
Performance
TARS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TARS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +75.4% |
| 3 y3 years | - | +75.4% |
| 5 y5 years | - | +75.4% |
TARS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -2.4% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -2.4% | -100.0% |
| alltime | all time | at high | -100.0% | -2.4% | -100.0% |
Tarsus Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.16 M(-1.3%) |
| Jun 2024 | - | $29.53 M(-1.2%) |
| Mar 2024 | - | $29.89 M(+79.8%) |
| Dec 2023 | $16.62 M(>+9900.0%) | $16.62 M(+210.0%) |
| Sep 2023 | - | $5.36 M(+114.5%) |
| Mar 2023 | - | $2.50 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $0.00 | $0.00(-100.0%) |
| Sep 2022 | - | $17.00 K(0.0%) |
| Jun 2022 | - | $17.00 K(0.0%) |
| Mar 2022 | - | $17.00 K(-99.9%) |
| Jun 2021 | - | $20.00 M(-20.0%) |
| Mar 2021 | - | $25.00 M |
FAQ
- What is Tarsus Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual accounts receivable year-on-year change?
- What is Tarsus Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Tarsus Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of TARS is $16.62 M
What is the all time high annual accounts receivable for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual accounts receivable is $16.62 M
What is Tarsus Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, TARS annual accounts receivable has changed by +$16.62 M (+100.00%)
What is Tarsus Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of TARS is $29.16 M
What is the all time high quarterly accounts receivable for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly accounts receivable is $29.89 M
What is Tarsus Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, TARS quarterly accounts receivable has changed by +$12.54 M (+75.43%)